LCM Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Sell |
3,301
-17
| -0.5% | -$2.06K | 0.21% | 62 |
|
|
2025
Q1 | $370K | Buy |
3,318
+58
| +2% | +$6.47K | 0.22% | 61 |
|
|
2024
Q4 | $317K | Buy |
3,260
+5
| +0.2% | +$487 | 0.18% | 70 |
|
|
2024
Q3 | $374K | Buy |
3,255
+53
| +2% | +$6.1K | 0.22% | 60 |
|
|
2024
Q2 | $341K | Buy |
3,202
+86
| +3% | +$9.16K | 0.21% | 59 |
|
|
2024
Q1 | $301K | Buy |
3,116
+16
| +0.5% | +$1.55K | 0.19% | 67 |
|
|
2023
Q4 | $313K | Buy |
3,100
+18
| +0.6% | +$1.82K | 0.23% | 62 |
|
|
2023
Q3 | $314K | Buy |
3,082
+128
| +4% | +$13K | 0.26% | 59 |
|
|
2023
Q2 | $298K | Buy |
2,954
+68
| +2% | +$6.86K | 0.24% | 62 |
|
|
2023
Q1 | $266K | Buy |
2,886
+173
| +6% | +$15.9K | 0.23% | 66 |
|
|
2022
Q4 | $246K | Buy |
2,713
+11
| +0.4% | +$998 | 0.24% | 65 |
|
|
2022
Q3 | $205K | Sell |
2,702
-10
| -0.4% | -$759 | 0.22% | 74 |
|
|
2022
Q2 | $229K | Sell |
2,712
-20
| -0.7% | -$1.69K | 0.23% | 69 |
|
|
2022
Q1 | $240K | Buy |
2,732
+49
| +2% | +$4.31K | 0.19% | 79 |
|
|
2021
Q4 | $235K | Buy |
2,683
+118
| +5% | +$10.3K | 0.18% | 79 |
|
|
2021
Q3 | $210K | Buy |
2,565
+5
| +0.2% | +$409 | 0.18% | 82 |
|
|
2021
Q2 | $234K | Buy |
2,560
+34
| +1% | +$3.11K | 0.19% | 74 |
|
|
2021
Q1 | $216K | Sell |
2,526
-96
| -4% | -$8.21K | 0.19% | 78 |
|
|
2020
Q4 | $245K | Buy |
+2,622
| New | +$245K | 0.23% | 63 |
|